Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)

v3.20.2
Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Equity [Abstract]  
Stock Option Outstanding, Beginning Balance 99,833
Stock Option Outstanding, Granted 3,000,000
Stock Option Outstanding, Cancelled (80,232)
Stock Option Outstanding, Exercised
Stock Option Outstanding, Ending Balance 3,019,601
Stock Option Outstanding, Exercisable Ending Balance 269,601
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 27.81
Weighted Average Exercise Price, Granted | $ / shares 0.15
Weighted Average Exercise Price, Cancelled | $ / shares 21.86
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Ending Balance | $ / shares $ 0.50
Weighted Average Remaining Contractual Term (years), Outstanding Beginning 2 years 7 days
Weighted Average Remaining Contractual Term (years), Granted 1 year 10 months 25 days
Weighted Average Remaining Contractual Term (years), Cancelled 2 months 1 day
Weighted Average Remaining Contractual Term (years), Outstanding Ending 3 years 2 months 23 days
Aggregated Intrinsic Value, Outstanding Ending | $